NasdaqGM - Delayed Quote USD
Foghorn Therapeutics Inc. (FHTX)
4.2000
-0.3300
(-7.28%)
At close: May 9 at 4:00:00 PM EDT
4.4100
+0.21
+(5.00%)
After hours: May 9 at 5:01:31 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
283,982
285,916
404,883
519,774
Total Liabilities Net Minority Interest
329,510
363,106
404,771
422,903
Total Equity Gross Minority Interest
-45,528
-77,190
112
96,871
Total Capitalization
-45,528
-77,190
112
96,871
Common Stock Equity
-45,528
-77,190
112
96,871
Capital Lease Obligations
37,131
45,073
51,507
58,332
Net Tangible Assets
-45,528
-77,190
112
96,871
Working Capital
182,612
181,745
296,194
410,870
Invested Capital
-45,528
-77,190
112
96,871
Tangible Book Value
-45,528
-77,190
112
96,871
Total Debt
37,131
45,073
51,507
58,332
Share Issued
55,593.1310
42,282.0400
41,803.4360
41,299.7200
Ordinary Shares Number
55,593.1310
42,282.0400
41,803.4360
41,299.7200
12/31/2021 - 10/23/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PRLD Prelude Therapeutics Incorporated
0.7810
-4.49%
STTK Shattuck Labs, Inc.
0.9479
+0.88%
CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%
KYMR Kymera Therapeutics, Inc.
30.07
-2.27%
SLDB Solid Biosciences Inc.
2.7600
-0.36%
CCCC C4 Therapeutics, Inc.
1.4700
-4.55%
EWTX Edgewise Therapeutics, Inc.
14.58
-0.82%
DSGN Design Therapeutics, Inc.
3.5000
-0.57%
NRIX Nurix Therapeutics, Inc.
9.50
-1.45%
STOK Stoke Therapeutics, Inc.
9.36
+3.43%